SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-003263
Filing Date
2022-02-22
Accepted
2022-02-22 09:03:52
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20211231.htm   iXBRL 10-K 2277884
2 EX-23.1 ex-231q42021.htm EX-23.1 9339
3 EX-31.1 ex-311q42021.htm EX-31.1 10028
4 EX-31.2 ex-312q42021.htm EX-31.2 10587
5 EX-32.1 ex-321q42021.htm EX-32.1 6309
11 espr-20211231_g1.jpg GRAPHIC 136565
  Complete submission text file 0001628280-22-003263.txt   9777746

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20211231.xsd EX-101.SCH 69447
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20211231_cal.xml EX-101.CAL 77413
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20211231_def.xml EX-101.DEF 342442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20211231_lab.xml EX-101.LAB 845335
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20211231_pre.xml EX-101.PRE 554840
82 EXTRACTED XBRL INSTANCE DOCUMENT espr-20211231_htm.xml XML 1354533
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 22655438
SIC: 2834 Pharmaceutical Preparations